143 related articles for article (PubMed ID: 35753435)
1. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
[TBL] [Abstract][Full Text] [Related]
2. Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment:
Abdel-Wahab ND; Kabil MF; El-Sherbiny IM; Salama MF; El-Sayed G; El-Sherbini ES
Drug Dev Ind Pharm; 2024 Mar; 50(3):223-235. PubMed ID: 38305197
[TBL] [Abstract][Full Text] [Related]
3. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
4. An
Radwan Y; Arafa KK; Ghoniem MG; Al-Farraj ES; El-Sherbiny IM
Drug Dev Ind Pharm; 2023 Mar; 49(3):271-280. PubMed ID: 37067846
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
Basu SM; Yadava SK; Singh R; Giri J
Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
9. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
10. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ
Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892
[TBL] [Abstract][Full Text] [Related]
11. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells.
Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z
AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292
[TBL] [Abstract][Full Text] [Related]
13. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and genotoxicity of lipid nanocapsules.
Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F
Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104
[TBL] [Abstract][Full Text] [Related]
16. Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer.
Haggag YA; Ibrahim RR; Hafiz AA
Int J Nanomedicine; 2020; 15():1625-1642. PubMed ID: 32210557
[TBL] [Abstract][Full Text] [Related]
17. Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
Ashour AA; El-Kamel AH; Abdelmonsif DA; Khalifa HM; Ramadan AA
Int J Nanomedicine; 2021; 16():8013-8033. PubMed ID: 34916792
[TBL] [Abstract][Full Text] [Related]
18. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
19. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
20. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]